By | February 28, 2014

Pharmaceutical News Wrap Up: February 2014

The pharmaceutical lawyers at the Firm are committed to keeping you up-to-date on the latest pharmaceutical news. Below is a short list of some of the most recent headlines concerning FDA recalls,… Read More

By | February 24, 2014

Studies Point to Inconsistencies in FDA Approval Process

Three new studies took a deeper look into the U.S. Food and Drug Administration (FDA) regulatory process. Results from the studies found that FDA approval does not necessarily mean the medication or… Read More

By | February 14, 2014

Study Finds Antioxidant Supplements May Accelerate Cancer Growth

Two antioxidants, vitamin E and beta carotene may do more harm than good in lung cancer patients, a new study suggests. Researchers showed that, antioxidants accelerated the progression of tumors in mice… Read More

By | February 7, 2014

New Study Verifies Need for Updated Warning Label on Low T Drugs

A recent large study backs up findings from previous smaller studies that found low T treatments increase risk of heart attack, stroke or death among men. The new study analyzed data from… Read More

By | February 5, 2014

Simmons Hanly Conroy Files First Testosterone Treatment Lawsuits, Bloomberg Reports

Attorneys at the Firm filed yesterday the first testosterone treatment lawsuits on behalf of five men against Abbott Laboratoes and AbbVie, Inc. The men range in age from 50 to 63 and… Read More

By | January 31, 2014

FDA Investigating Risk of Testosterone Causing Cardiovascular Events

The U.S. Food & Drug Administration is investigating the risk of testosterone treatments causing an increased rate of cardiovascular events such as heart attacks and stroke, according to a drug safety communication from the… Read More

By | January 30, 2014

Testosterone therapy doubles risk of heart attack, stroke in men

Men taking testosterone therapy face an increased risk of heart attack or stroke, according to new research. The study, titled “Increased Risk of Non-Fatal Myocardial Infarction Following Testosterone Therapy Prescription in Men,” was published… Read More

By | January 24, 2014

Study Finds Sharp Increase in Testosterone Use

Testosterone use among older men has drastically increased over the past decade, with more men being tested for low testosterone levels and subsequently being prescribed low T treatments. According to a new… Read More

By | January 17, 2014

Tighter Control Needed on Prescription Drugs, ACP Says

Prescription painkillers are the most abused type of prescription drugs in the United States. To address this problem, the American College of Physicians released recommended guidelines for preventing painkiller prescription abuse in… Read More

By | December 30, 2013

Generic Drug Competition Shrinks Pfizer’s Profit

Pharmaceutical giant Pfizer had a massive decrease in third-quarter profit due to the increased competition from generic drugs, according to the New York Times. As more generic drugs become available and are… Read More